CJC-1295 + Ipamorelin

Product Overview

• Core Blend: CJC-1295 (No DAC) + Ipamorelin

• Ratio: [Insert Ratio, e.g., 5mg/5mg or 2mg/2mg] Precision Blended

• Research Grade: Amino Grade / High Purity HPLC Tested

• Formulation: Lyophilized (Freeze-Dried) Solid

• Mechanism: Dual-Pathway Growth Hormone Secretagogue (GHS)

Key Research Highlights

• Synergistic GH Release: Combines a GHRH (CJC-1295) with a GHRP (Ipamorelin) to trigger a more potent growth hormone pulse than either peptide used in isolation.

• Selective Action: Ipamorelin is researched for its high selectivity, stimulating GH without significant increases in cortisol, prolactin, or appetite-stimulating ghrelin.

• Extended Bioavailability: CJC-1295 (No DAC) is studied for its ability to extend the half-life of GHRH signaling, providing a more sustained physiological response.

• Metabolic & Tissue Research: Frequently utilized in studies regarding muscle protein synthesis, adipose tissue lipolysis, and cellular repair mechanisms.

• No DAC Advantage: This formulation utilizes the "No DAC" (CJC-1295 AF) version, preferred in research for mimicking natural, episodic GH pulses rather than constant bleeding levels.

Technical Specifications & Quality

• Purity: Each component verified at ≥99% purity via HPLC and Mass Spectrometry.

• Molecular Profiles: * CJC-1295: 29 Amino Acid Peptide ($TetrasubstitutedGHRH1-29$).

  • Ipamorelin: 5 Amino Acid Pentapeptide ($Aib-His-D-2-Nal-D-Phe-Lys-NH2$).

• Manufacturing: Produced via solid-phase synthesis in a cGMP-compliant facility.

• Solubility: Rapidly and completely soluble in Bacteriostatic Water.